12:00 AM
 | 
Feb 28, 2011
 |  BC Week In Review  |  Company News  |  Deals

bioMerieux, Ipsen deal

bioMerieux and Ipsen partnered to co-develop hormone-dependent cancer therapeutics and companion diagnostics. Ipsen will provide compounds, while...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >